Suppr超能文献

了解患者和临床利益相关者的观点,以提高肺癌筛查的依从性。

Understanding Patient and Clinical Stakeholder Perspectives to Improve Adherence to Lung Cancer Screening.

机构信息

Kaiser Permanente Washington Health Research Institute, Seattle, WA.

出版信息

Perm J. 2021 Jun 2;25:20.295. doi: 10.7812/TPP/20.295.

Abstract

INTRODUCTION

Limited evidence-based implementation strategies exist for maintaining lung cancer screening. We evaluated the Lung Cancer Screening Program at Kaiser Permanente Washington (KPWA) to develop multilevel interventions to improve screening adherence.

METHODS

We conducted a concurrent mixed-methods study 1) to measure adherence to repeat screening with low-dose computed tomography (LDCT); 2) to interview KPWA stakeholders to understand the Lung Cancer Screening Program; and 3) to conduct codesign workshops with KPWA members and researchers. We used descriptive statistics to describe adherence, and rapid qualitative data analysis for stakeholder interviews and workshops.

RESULTS

Between 2015 and 2019, 2089 KPWA members had initial LDCT scans with negative, benign or short-interval follow-up results. Among those with sufficient follow-up, the proportion with on-time repeat screening after a negative LDCT was 26.4% after the initial scan, and increased to 43.1% on subsequent scans. Opportunities for health-care system improvement included clarification of clinical roles and responsibilities, care coordination across providers, ongoing training in lung cancer screening, and revising electronic health record tools. From patient perspectives, facilitators to repeat screening were making screening personalized and convenient; offering consistent messages and reminders in different modes; increasing patient knowledge about benefits, harms, and expectations of LDCT; and providing nonfinancial and financial incentives for adherence. From a storyboard exercise, we identified 10 design features for lung cancer screening interventions, including versatility of communication, social support, and knowledge.

CONCLUSION

We identified clear gaps in adherence to lung cancer screenings, organizational and clinical barriers to care, and design features for patient-centered interventions to improve lung cancer screening in US settings.

摘要

简介

目前针对维持肺癌筛查的循证实施策略有限。我们评估了 Kaiser Permanente Washington(KPWA)的肺癌筛查计划,以制定多层次干预措施来提高筛查的依从性。

方法

我们同时进行了一项混合方法研究,1)测量低剂量计算机断层扫描(LDCT)重复筛查的依从性;2)对 KPWA 利益相关者进行访谈,以了解肺癌筛查计划;3)与 KPWA 成员和研究人员进行共同设计研讨会。我们使用描述性统计来描述依从性,并对利益相关者访谈和研讨会进行快速定性数据分析。

结果

在 2015 年至 2019 年期间,2089 名 KPWA 成员进行了初始 LDCT 扫描,结果为阴性、良性或短期随访。在有足够随访的人群中,初始 LDCT 扫描阴性后按时进行重复筛查的比例为首次扫描后的 26.4%,随后扫描时增加到 43.1%。改善医疗保健系统的机会包括明确临床角色和责任、协调提供者之间的护理、持续进行肺癌筛查培训以及修改电子健康记录工具。从患者角度来看,促进重复筛查的因素包括使筛查个性化和便利化;以不同模式提供一致的信息和提醒;提高患者对 LDCT 的益处、危害和预期的了解;以及提供非财务和财务激励措施以提高依从性。从故事板练习中,我们确定了 10 个肺癌筛查干预措施的设计特征,包括沟通的多功能性、社会支持和知识。

结论

我们确定了肺癌筛查的依从性存在明显差距,以及对护理的组织和临床障碍,以及针对以患者为中心的干预措施的设计特征,以改善美国的肺癌筛查。

相似文献

4
5
Timely adherence to follow-up after high-risk lung cancer screenings.
J Med Screen. 2023 Sep;30(3):150-155. doi: 10.1177/09691413231162507. Epub 2023 Mar 14.
6
Adherence to annual lung cancer screening with low-dose CT scan in a diverse population.
Cancer Causes Control. 2021 Mar;32(3):291-298. doi: 10.1007/s10552-020-01383-0. Epub 2021 Jan 4.
7
Increasing uptake to a lung cancer screening programme: building with communities through co-design.
BMC Public Health. 2022 Apr 23;22(1):815. doi: 10.1186/s12889-022-12998-0.
8
Patient Adherence in an Academic Medical Center's Low-dose Computed Tomography Screening Program.
Am J Clin Oncol. 2021 Jun 1;44(6):264-268. doi: 10.1097/COC.0000000000000817.
9
Nurse practitioner-led lung cancer screening clinic: An evidence-based quality improvement evaluation.
Worldviews Evid Based Nurs. 2022 Jun;19(3):227-234. doi: 10.1111/wvn.12578. Epub 2022 May 17.
10
Patient and Clinician Recommendations to Improve Communication and Understanding of Lung Cancer Screening Results.
Chest. 2023 Mar;163(3):707-718. doi: 10.1016/j.chest.2022.09.038. Epub 2022 Oct 6.

本文引用的文献

3
Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial.
N Engl J Med. 2020 Feb 6;382(6):503-513. doi: 10.1056/NEJMoa1911793. Epub 2020 Jan 29.
4
Evaluating Lung Cancer Screening Across Diverse Healthcare Systems: A Process Model from the Lung PROSPR Consortium.
Cancer Prev Res (Phila). 2020 Feb;13(2):129-136. doi: 10.1158/1940-6207.CAPR-19-0378. Epub 2019 Dec 23.
5
Video-Based Interventions for Cancer Control: A Systematic Review.
Health Educ Behav. 2020 Apr;47(2):249-257. doi: 10.1177/1090198119887210. Epub 2019 Nov 8.
7
Barriers to Lung Cancer Screening With Low-Dose Computed Tomography.
Oncol Nurs Forum. 2019 Mar 1;46(2):E60-E71. doi: 10.1188/19.ONF.E60-E71.
9
Lung Cancer Risk Associated With New Solid Nodules in the National Lung Screening Trial.
AJR Am J Roentgenol. 2017 Nov;209(5):1009-1014. doi: 10.2214/AJR.17.18252. Epub 2017 Sep 12.
10
Creating Conditions for Patients' Values to Emerge in Clinical Conversations: Perspectives of Health Care Team Members.
DIS (Des Interact Syst Conf). 2017 Jun;2017:1165-1174. doi: 10.1145/3064663.3064669.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验